Clinical Trials Directory

Trials / Completed

CompletedNCT02483442

D-dimer Testing Tailored to Clinical Pretest Probability in Suspected Pulmonary Embolism

D-dimer Testing,Tailored to Clinical Pretest Probability to Reduce the Use of CT Pulmonary Angiography in Suspected Pulmonary Embolism: A Management Study (The Pulmonary Embolism Graduated D-dimer [PEGeD] Study)

Status
Completed
Phase
Study type
Observational
Enrollment
2,038 (actual)
Sponsor
McMaster University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective, multicentre, cohort study assessing a diagnostic management strategy for suspected Pulmonary Embolism with independent central adjudication of outcomes

Detailed description

This is a prospective, multi-centre, cohort study that will assess a new diagnostic management strategy for suspected Pulmonary Embolism (inpatients and outpatients). The new diagnostic strategy is designed to reduce the use of imaging tests for Pulmonary Embolism, particularly Computed Tomography Pulmonary Angiogram, by excluding Pulmonary Embolism with combinations of Clinical Pretest Probability and D-dimer results in a higher proportion of patients. The safety of this management strategy will be established by demonstrating a very low rate of proximal Deep Vein Thrombosis or Pulmonary Embolism during 90 days of follow-up in patients who had anticoagulant therapy withheld in response to negative diagnostic testing. Diagnostic test utilization will be assessed. All clinical outcomes will be adjudicated by a central independent adjudication committee that will be blind to initial D-dimer measurements and patient management.

Conditions

Timeline

Start date
2015-12-11
Primary completion
2019-02-07
Completion
2019-09-24
First posted
2015-06-29
Last updated
2023-02-06

Locations

9 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT02483442. Inclusion in this directory is not an endorsement.